Literature DB >> 34370164

Improving workflow in prostate MRI: AI-based decision-making on biparametric or multiparametric MRI.

Andreas M Hötker1, Raffaele Da Mutten2, Anja Tiessen2, Ender Konukoglu3, Olivio F Donati2.   

Abstract

OBJECTIVES: To develop and validate an artificial intelligence algorithm to decide on the necessity of dynamic contrast-enhanced sequences (DCE) in prostate MRI.
METHODS: This study was approved by the institutional review board and requirement for study-specific informed consent was waived. A convolutional neural network (CNN) was developed on 300 prostate MRI examinations. Consensus of two expert readers on the necessity of DCE acted as reference standard. The CNN was validated in a separate cohort of 100 prostate MRI examinations from the same vendor and 31 examinations from a different vendor. Sensitivity/specificity were calculated using ROC curve analysis and results were compared to decisions made by a radiology technician.
RESULTS: The CNN reached a sensitivity of 94.4% and specificity of 68.8% (AUC: 0.88) for the necessity of DCE, correctly assigning 44%/34% of patients to a biparametric/multiparametric protocol. In 2% of all patients, the CNN incorrectly decided on omitting DCE. With a technician reaching a sensitivity of 63.9% and specificity of 89.1%, the use of the CNN would allow for an increase in sensitivity of 30.5%. The CNN achieved an AUC of 0.73 in a set of examinations from a different vendor.
CONCLUSIONS: The CNN would have correctly assigned 78% of patients to a biparametric or multiparametric protocol, with only 2% of all patients requiring re-examination to add DCE sequences. Integrating this CNN in clinical routine could render the requirement for on-table monitoring obsolete by performing contrast-enhanced MRI only when needed.
© 2021. The Author(s).

Entities:  

Keywords:  Artificial Intelligence; Multiparametric MRI; Prostate cancer

Year:  2021        PMID: 34370164     DOI: 10.1186/s13244-021-01058-7

Source DB:  PubMed          Journal:  Insights Imaging        ISSN: 1869-4101


  19 in total

1.  Let's Follow the Golden Mean: Using Magnetic Resonance Imaging to Determine the Need for Biopsy in Men on Active Surveillance.

Authors:  Caroline M Moore; Alexander P Cole; Clare Allen; Francesco Giganti
Journal:  Eur Urol Oncol       Date:  2020-12-23

2.  Diagnostic accuracy of the PROMIS study - Authors' reply.

Authors:  Hashim U Ahmed; Louise C Brown; Richard Kaplan; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-07-22       Impact factor: 79.321

3.  Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study.

Authors:  Borna K Barth; Pieter J L De Visschere; Alexander Cornelius; Carlos Nicolau; Hebert Alberto Vargas; Daniel Eberli; Olivio F Donati
Journal:  Radiology       Date:  2017-03-27       Impact factor: 11.105

4.  Detecting Prostate Cancer with Deep Learning for MRI: A Small Step Forward.

Authors:  Anwar R Padhani; Baris Turkbey
Journal:  Radiology       Date:  2019-10-08       Impact factor: 11.105

5.  Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging.

Authors:  Philipp Boehm-Sturm; Akvile Haeckel; Ralf Hauptmann; Susanne Mueller; Christiane K Kuhl; Eyk A Schellenberger
Journal:  Radiology       Date:  2017-09-07       Impact factor: 11.105

6.  Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer.

Authors:  Urs J Muehlematter; Irene A Burger; Anton S Becker; Khoschy Schawkat; Andreas M Hötker; Cäcilia S Reiner; Julian Müller; Niels J Rupp; Jan H Rüschoff; Daniel Eberli; Olivio F Donati
Journal:  Radiology       Date:  2019-09-10       Impact factor: 11.105

7.  EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.

Authors:  J Alfred Witjes; Marek Babjuk; Joaquim Bellmunt; H Maxim Bruins; Theo M De Reijke; Maria De Santis; Silke Gillessen; Nicholas James; Steven Maclennan; Juan Palou; Tom Powles; Maria J Ribal; Shahrokh F Shariat; Theo Van Der Kwast; Evanguelos Xylinas; Neeraj Agarwal; Tom Arends; Aristotle Bamias; Alison Birtle; Peter C Black; Bernard H Bochner; Michel Bolla; Joost L Boormans; Alberto Bossi; Alberto Briganti; Iris Brummelhuis; Max Burger; Daniel Castellano; Richard Cathomas; Arturo Chiti; Ananya Choudhury; Eva Compérat; Simon Crabb; Stephane Culine; Berardino De Bari; Willem De Blok; Pieter J L De Visschere; Karel Decaestecker; Konstantinos Dimitropoulos; Jose L Dominguez-Escrig; Stefano Fanti; Valerie Fonteyne; Mark Frydenberg; Jurgen J Futterer; Georgios Gakis; Bogdan Geavlete; Paolo Gontero; Bernhard Grubmüller; Shaista Hafeez; Donna E Hansel; Arndt Hartmann; Dickon Hayne; Ann M Henry; Virginia Hernandez; Harry Herr; Ken Herrmann; Peter Hoskin; Jorge Huguet; Barbara A Jereczek-Fossa; Rob Jones; Ashish M Kamat; Vincent Khoo; Anne E Kiltie; Susanne Krege; Sylvain Ladoire; Pedro C Lara; Annemarie Leliveld; Estefania Linares-Espinós; Vibeke Løgager; Anja Lorch; Yohann Loriot; Richard Meijer; M Carmen Mir; Marco Moschini; Hugh Mostafid; Arndt-Christian Müller; Christoph R Müller; James N'Dow; Andrea Necchi; Yann Neuzillet; Jorg R Oddens; Jan Oldenburg; Susanne Osanto; Wim J G Oyen; Luís Pacheco-Figueiredo; Helle Pappot; Manish I Patel; Bradley R Pieters; Karin Plass; Mesut Remzi; Margitta Retz; Jonathan Richenberg; Michael Rink; Florian Roghmann; Jonathan E Rosenberg; Morgan Rouprêt; Olivier Rouvière; Carl Salembier; Antti Salminen; Paul Sargos; Shomik Sengupta; Amir Sherif; Robert J Smeenk; Anita Smits; Arnulf Stenzl; George N Thalmann; Bertrand Tombal; Baris Turkbey; Susanne Vahr Lauridsen; Riccardo Valdagni; Antoine G Van Der Heijden; Hein Van Poppel; Mihai D Vartolomei; Erik Veskimäe; Antoni Vilaseca; Franklin A Vives Rivera; Thomas Wiegel; Peter Wiklund; Andrew Williams; Richard Zigeuner; Alan Horwich
Journal:  Eur Urol       Date:  2019-11-19       Impact factor: 20.096

8.  A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.

Authors:  Sherif Mehralivand; Joanna H Shih; Stephanie Harmon; Clayton Smith; Jonathan Bloom; Marcin Czarniecki; Samuel Gold; Graham Hale; Kareem Rayn; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Radiology       Date:  2019-01-22       Impact factor: 11.105

9.  Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies.

Authors:  Juha Knaapila; Ivan Jambor; Otto Ettala; Pekka Taimen; Janne Verho; Ileana Montoya Perez; Aida Kiviniemi; Tapio Pahikkala; Harri Merisaari; Tarja Lamminen; Jani Saunavaara; Hannu J Aronen; Kari T Syvänen; Peter J Boström
Journal:  Eur Urol Focus       Date:  2020-05-14

10.  False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS.

Authors:  Vasilis Stavrinides; Tom Syer; Yipeng Hu; Francesco Giganti; Alex Freeman; Solon Karapanagiotis; Simon R J Bott; Louise C Brown; Nicholas Burns-Cox; Timothy J Dudderidge; Ahmed El-Shater Bosaily; Elena Frangou; Maneesh Ghei; Alastair Henderson; Richard G Hindley; Richard S Kaplan; Robert Oldroyd; Chris Parker; Raj Persad; Derek J Rosario; Iqbal S Shergill; Lina M Carmona Echeverria; Joseph M Norris; Mathias Winkler; Dean Barratt; Alex Kirkham; Shonit Punwani; Hayley C Whitaker; Hashim U Ahmed; Mark Emberton
Journal:  Eur Urol       Date:  2020-10-10       Impact factor: 20.096

View more
  1 in total

Review 1.  Abbreviated MR Protocols in Prostate MRI.

Authors:  Andreas M Hötker; Hebert Alberto Vargas; Olivio F Donati
Journal:  Life (Basel)       Date:  2022-04-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.